Phototherapy and mycosis fungoides: what’s new?
Paolo Iacovelli, Alessia Pacifico, Maria Mariano, Diego Orsini, Andrea D’Arino, Flavia Pigliacelli
Abstract
Open-access reader
Paolo Iacovelli, Alessia Pacifico, Maria Mariano, Diego Orsini, Andrea D’Arino, Flavia Pigliacelli
Abstract
Open-access reader
The most common cutaneous T-cell lymphoma, mycosis fungoides (MF), is clinically characterized by erythematous-violaceous nodules and erythematous-scaly patches. In the early stages of MF, phototherapy is currently the first line of treatment and plays a significant role. This study aims to review and analyze the various phototherapy options for cutaneous lymphoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The most common cutaneous T-cell lymphoma, mycosis fungoides (MF), is clinically characterized by erythematous-violaceous nodules and erythematous-scaly patches. In the early stages of MF, phototherapy is currently the first line of treatment and plays a significant role. This study aims to review and analyze the various phototherapy options for cutaneous lymphoma.
Key concepts: Mycosis fungoides, Medicine, Dermatology, Pathology, Lymphoma